Ghana vs Mauritania: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Mauritania
100.0%
in 2023
Ghana rank
1st
Mauritania rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Mauritania
How they compare
Ghana currently reports 100.0% against 100.0% in Mauritania, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2005 it was Mauritania ahead.
Ghana ranks 1st and Mauritania ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 1 and Mauritania in 2.
Head to head by decade
| Decade | Ghana | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 9.1% | 2.4% | Mauritania |
| 2010s | 84.1% | 44.7% | 39.4% | Ghana |
| 2020s | 98.2% | 100.0% | 1.8% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Mauritania?
- Ghana, at 100.0% against 100.0% in Mauritania as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Mauritania?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Mauritania?
- 12 years are reported by both, from 2005 to 2023.
- How do Ghana and Mauritania rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Mauritania ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.